|
Quotes & Info
|
| PBYI > SEC Filings for PBYI > Form 8-K on 13-Jun-2012 | All Recent SEC Filings |
13-Jun-2012
Entry into a Material Definitive Agreement, Financial Statements and Exh
On June 7, 2012, Puma Biotechnology, Inc., a Delaware corporation (the "Company"), entered into an Office Lease (the "Lease") with DWF III Gateway, LLC, a Delaware limited liability company, for approximately 9,560 rentable square feet of office space in the building located at 701 Gateway Boulevard, South San Francisco, California 94080. The Company plans to use the premises for general office and administrative purposes.
The initial term of the Lease is for seven years and is expected to commence on or about Oct 1, 2012. The base rent will be approximately $20,250 per month during the first year and will increase over the course of the initial term, up to approximately $30,820 per month during the seventh year. In addition, the Company has an option to extend the Lease for an additional five-year term, which would commence upon the expiration of the initial term. In the event the Company elects to extend the Lease, the minimum monthly rent payable for the additional term will be the then-current fair market rent calculated in accordance with the terms of the Lease.
The foregoing summary of the Lease does not purport to be complete and is qualified in its entirety by reference to the full text of the Lease, a copy of which is filed as Exhibit 10.1 to this Current Report on Form 8-K and incorporated herein by reference.
(d) Exhibits.
10.1 Office Lease by and between Puma Biotechnology, Inc. and DWF III Gateway, LLC, executed on June 7, 2012
|
|